APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $59,321,496 | +45.6% | 651,169 | +5.4% | 0.13% | +28.4% |
| Q1 2023 | $40,756,486 | +207.5% | 617,897 | +141.0% | 0.10% | +183.3% |
| Q4 2022 | $13,255,393 | +310.6% | 256,341 | +442.3% | 0.04% | +260.0% |
| Q3 2022 | $3,228,000 | -46.9% | 47,265 | -63.2% | 0.01% | -52.4% |
| Q4 2021 | $6,076,000 | +0.6% | 128,514 | -29.8% | 0.02% | -16.0% |
| Q3 2021 | $6,037,000 | +465.8% | 183,147 | +205.2% | 0.02% | +400.0% |
| Q3 2018 | $1,067,000 | -25.9% | 60,000 | -8.3% | 0.01% | -28.6% |
| Q2 2018 | $1,439,000 | – | 65,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |